Mutation analyses of the NFAT1 gene in chondrosarcomas and enchondromas

被引:11
作者
Aoyama, T
Nagayama, S
Okamoto, T
Hosaka, T
Nakamata, T
Nishijo, K
Tsuboyama, T
Nakayama, T
Nakamura, T
Toguchida, J
机构
[1] Kyoto Univ, Inst Frontier Med Sci, Sakyo Ku, Kyoto 6068507, Japan
[2] Kyoto Univ, Grad Sch Med, Dept Orthopaed Surg, Kyoto 6068507, Japan
[3] Grad Sch Med, Dept Surg & Surg Basic Sci, Kyoto 6068507, Japan
[4] Kyoto Univ, Coll Med Technol, Kyoto 6068507, Japan
关键词
nuclear factor of activated T cell 1; chondrosarcoma; enchondroma; tumor suppressor;
D O I
10.1016/S0304-3835(02)00106-4
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
Mice lacking nuclear factor of activated T cell I (NFAT1 ) showed an abnormal proliferation of chondrocytes in articular cartilage and formed an extraosseous cartilaginous mass resembling a neoplastic lesion, suggesting that the NFAT1 gene is a tumor suppressor gene in cartilaginous neoplasms. Here we performed mutation analyses of the NFAT1 gene in human cartilaginous tumors including 30 chondrosarcomas and 15 enchondromas. Reverse transcription-polymerase chain reaction (PCR) analysis revealed the expression of the NFAT1 gene in 15/15 chondrosarcomas and 12/13 enchondromas. To find subtle alterations, the genomic structure of the NFAT1 gene was determined using human genome draft sequences, and a mutation analysis was performed using the exon-by-exon PCR-single-strand conformation polymorphism method. Two heterozygous missense mutations, Al557T (His446Leu) and C2859T (Pro880Leu), were found in eight tumor samples, but the same mutation was also present in the constitutional cells of corresponding patients. The incidence of the mutant alleles in the patient and control groups showed no significant difference, suggesting that these mutations are rare single nucleotide polymorphisms unrelated with tumorigenesis. These results suggest that the NFAT I gene is not likely to be a tumor suppressor gene in human cartilaginous tumors. (C) 2002 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:49 / 57
页数:9
相关论文
共 45 条
[1]
CLONING OF THE PUTATIVE TUMOR-SUPPRESSOR GENE FOR HEREDITARY MULTIPLE EXOSTOSES (EXT1) [J].
AHN, J ;
JOSEFLUDECKE, H ;
LINDOW, S ;
HORTON, WA ;
LEE, B ;
WAGNER, MJ ;
HORSTHEMKE, B ;
WELLS, DE .
NATURE GENETICS, 1995, 11 (02) :137-143
[2]
Asp J, 2000, INT J CANCER, V85, P782, DOI 10.1002/(SICI)1097-0215(20000315)85:6<782::AID-IJC7>3.0.CO
[3]
2-O
[4]
Microvasculature and VEGF expression in cartilaginous tumors [J].
Ayala, G ;
Liu, C ;
Nicosia, R ;
Horowitz, S ;
Lackman, R .
HUMAN PATHOLOGY, 2000, 31 (03) :341-346
[5]
Bovée JVMG, 1999, J PATHOL, V189, P454, DOI 10.1002/(SICI)1096-9896(199912)189:4<454::AID-PATH467>3.0.CO
[6]
2-N
[7]
EXT-mutation analysis and loss of heterozygosity in sporadic and hereditary osteochondromas and secondary chondrosarcomas [J].
Bovée, JVMG ;
Cleton-Jansen, AM ;
Wuyts, W ;
Caethoven, G ;
Taminiau, AHM ;
Bakker, E ;
Van Hul, W ;
Cornelisse, CJ ;
Hogendoorn, PCW .
AMERICAN JOURNAL OF HUMAN GENETICS, 1999, 65 (03) :689-698
[8]
Up-regulation of PTHrP and Bcl-2 expression characterizes the progression of osteochondroma towards peripheral chondrosarcoma and is a late event in central chondrosarcoma [J].
Bovée, JVMG ;
van den Broek, LJCM ;
Cleton-Jansen, AM ;
Hogendoorn, PCW .
LABORATORY INVESTIGATION, 2000, 80 (12) :1925-1934
[10]
DOBASHI Y, 1993, DIAGN MOL PATHOL, V2, P257